Evidence map›Paper›PMID 31593272›Full record

SynthesisJAMA2019

Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage.

Joji B Kuramatsu, Alessandro Biffi, Stefan T Gerner, Jochen A Sembill, Maximilian I Sprügel, Audrey Leasure, Lauren Sansing, Charles Matouk, Guido J Falcone, Matthias Endres and 58 more

Open access · bronzeAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in JAMA, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 177 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. [In-hospital management of intracerebral hemorrhage].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

68 authors at 20 institutions in 2 countries.

Joji B KuramatsuDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Alessandro BiffiDepartment of Neurology, Massachusetts General Hospital, Boston.
Stefan T GernerDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Jochen A SembillDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Maximilian I SprügelDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Audrey LeasureDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Lauren SansingDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Charles MatoukDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Guido J FalconeDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Matthias EndresDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Karl Georg HaeuslerDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Jan SobeskyDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Johannes SchurigCenter for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sarah ZweynertDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Miriam BauerCenter for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Peter VajkoczyDepartment of Neurosurgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Peter A RinglebDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Jan PurruckerDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Timolaos RizosDepartment of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
Jens VolkmannDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Wolfgang MüllgesDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Peter KraftDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Anna-Lena SchubertDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Frank ErbguthDepartment of Neurology, Community Hospital Nuremberg, Nuremberg, Germany.
Martin NueckelDepartment of Neurology, Community Hospital Nuremberg, Nuremberg, Germany.
Peter D SchellingerDepartment of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, UK RUB, Minden, Germany.
Jörg GlahnDepartment of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, UK RUB, Minden, Germany.
Ulrich J KnappeDepartment of Neurosurgery, Johannes Wesling Medical Center Minden, UK RUB, Minden, Germany.
Gereon R FinkDepartment of Neurology, University of Cologne, Cologne, Germany.
Christian DohmenDepartment of Neurology, University of Cologne, Cologne, Germany.
Henning StetefeldDepartment of Neurology, University of Cologne, Cologne, Germany.
Anna Lena FisseDepartment of Neurology, University of Münster, Münster, Germany.
Jens MinnerupDepartment of Neurology, University of Münster, Münster, Germany.
Georg HagemannDepartment of Neurology, Community Hospital Helios Klinikum Berlin-Buch, Berlin, Germany.
Florian RakersDepartment of Neurology, Community Hospital Helios Klinikum Berlin-Buch, Berlin, Germany.
Heinz ReichmannDepartment of Neurology, University of Dresden, Dresden, Germany.
Hauke SchneiderDepartment of Neurology, University of Dresden, Dresden, Germany.
Jan RahmigDepartment of Neurology, University of Dresden, Dresden, Germany.
Albert Christian LudolphDepartment of Neurology, University of Ulm, Ulm, Germany.
Sebastian StösserDepartment of Neurology, University of Ulm, Ulm, Germany.
Hermann NeugebauerDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Joachim RötherDepartment of Neurology, Community Hospital Asklepios Klinik Hamburg Altona, Hamburg, Germany.
Peter MichelsDepartment of Neurology, Community Hospital Asklepios Klinik Hamburg Altona, Hamburg, Germany.
Michael SchwarzDepartment of Neurology, Community Hospital Klinikum Dortmund, Dortmund, Germany.
Gernot ReimannDepartment of Neurology, Community Hospital Klinikum Dortmund, Dortmund, Germany.
Hansjörg BäznerDepartment of Neurology, Community Hospital Klinikum Stuttgart, Stuttgart, Germany.
Henning SchwertDepartment of Neurology, Community Hospital Klinikum Stuttgart, Stuttgart, Germany.
Joseph ClaßenDepartment of Neurology, University of Leipzig, Leipzig, Germany.
Dominik MichalskiDepartment of Neurology, University of Leipzig, Leipzig, Germany.
Armin GrauDepartment of Neurology, Community Hospital Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.
Frederick PalmDepartment of Neurology, Community Hospital Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.
Christian UrbanekDepartment of Neurology, Community Hospital Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.
Johannes C WöhrleDepartment of Neurology, Community Hospital Klinikum Koblenz, Koblenz, Germany.
Fahid AlshammariDepartment of Neurology, Community Hospital Klinikum Koblenz, Koblenz, Germany.
Markus HornDepartment of Neurology, Community Hospital Bad Hersfeld, Bad Hersfeld, Germany.
Dirk BahnerDepartment of Neurology, Community Hospital Bad Hersfeld, Bad Hersfeld, Germany.
Otto W WitteDepartment of Neurology, University of Jena, Jena, Germany.
Albrecht GüntherDepartment of Neurology, University of Jena, Jena, Germany.
Gerhard F HamannDepartment of Neurology and Neurological Rehabilitation, Bezirkskrankenhaus Günzburg, Günzburg, Germany.
Manuel HagenDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Sebastian S RoederDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Hannes LückingDepartment of Neuroradiology, University of Erlangen-Nuremberg, Erlangen, Germany.
Arnd DörflerDepartment of Neuroradiology, University of Erlangen-Nuremberg, Erlangen, Germany.
Fernando D TestaiDepartment of Neurology and Rehabilitation, University of Illinois College of Medicine, Chicago.
Daniel WooDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio.
Stefan SchwabDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Kevin N ShethDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Hagen B HuttnerDepartment of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany.
Friedrich-Alexander-Universität Erlangen-Nürnberg · DECharité - Universitätsmedizin Berlin · DEUniversity of Würzburg · DEYale University · USJohannes Wesling Klinikum Minden · DEKlinikum Ludwigshafen · DETechnische Universität Dresden · DEUniversity of Cologne · DEAsklepios Klinik Altona · DEFriedrich Schiller University Jena · DEHelios Hospital Berlin-Buch · DEKatholisches Klinikum Koblenz · DEKlinikum Dortmund · DEKlinikum Stuttgart · DELeipzig University · DENuremberg Hospital · DEUniversität Ulm · DEUniversity of Münster · DEAlfried Krupp Hospital · DEFachkrankenhaus Hubertusburg · DE

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)U01NS069763 · NINDS · UNIVERSITY OF CINCINNATI · PI ANDERSON, CHRISTOPHER DAVID, DEMEL, STACIE · 2010 to 2024
$34.2M
Specialized Programs of Translational Research in Acute Stroke at the PartnersP50NS051343 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GREENBERG, STEVEN M · 2006 to 2013
$17.5M
Recurrent Hemorrhagic Stroke in Minority PopulationsR01NS093870 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI JONATHAN ROSAND, Amytis Towfighi · 2016 to 2026
$12.3M
Vascular Dysfunction in Cerebral Amyloid AngiopathyR01AG026484 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GREENBERG, STEVEN M · 2005 to 2019
$7.5M
NCATS NIH HHS UL1 TR001863NIA NIH HHS R01 AG026484NINDS NIH HHS P50 NS051343NINDS NIH HHS R01 NS093870NINDS NIH HHS U01 NS069763
6 · The paper itself

Abstract

Importance: The association of surgical hematoma evacuation with clinical outcomes in patients with cerebellar intracerebral hemorrhage (ICH) has not been established. Objective: To determine the association of surgical hematoma evacuation with clinical outcomes in cerebellar ICH. Design, Setting, and Participants: Individual participant data (IPD) meta-analysis of 4 observational ICH studies incorporating 6580 patients treated at 64 hospitals across the United States and Germany (2006-2015). Exposure: Surgical hematoma evacuation vs conservative treatment. Main Outcomes and Measures: The primary outcome was functional disability evaluated by the modified Rankin Scale ([mRS] score range: 0, no functional deficit to 6, death) at 3 months; favorable (mRS, 0-3) vs unfavorable (mRS, 4-6). Secondary outcomes included survival at 3 months and at 12 months. Analyses included propensity score matching and covariate adjustment, and predicted probabilities were used to identify treatment-related cutoff values for cerebellar ICH. Results: Among 578 patients with cerebellar ICH, propensity score-matched groups included 152 patients with surgical hematoma evacuation vs 152 patients with conservative treatment (age, 68.9 vs 69.2 years; men, 55.9% vs 51.3%; prior anticoagulation, 60.5% vs 63.8%; and median ICH volume, 20.5 cm3 vs 18.8 cm3). After adjustment, surgical hematoma evacuation vs conservative treatment was not significantly associated with likelihood of better functional disability at 3 months (30.9% vs 35.5%; adjusted odds ratio [AOR], 0.94 [95% CI, 0.81 to 1.09], P = .43; adjusted risk difference [ARD], -3.7% [95% CI, -8.7% to 1.2%]) but was significantly associated with greater probability of survival at 3 months (78.3% vs 61.2%; AOR, 1.25 [95% CI, 1.07 to 1.45], P = .005; ARD, 18.5% [95% CI, 13.8% to 23.2%]) and at 12 months (71.7% vs 57.2%; AOR, 1.21 [95% CI, 1.03 to 1.42], P = .02; ARD, 17.0% [95% CI, 11.5% to 22.6%]). A volume range of 12 to 15 cm3 was identified; below this level, surgical hematoma evacuation was associated with lower likelihood of favorable functional outcome (volume ≤12 cm3, 30.6% vs 62.3% [P = .003]; ARD, -34.7% [-38.8% to -30.6%]; P value for interaction, .01), and above, it was associated with greater likelihood of survival (volume ≥15 cm3, 74.5% vs 45.1% [P < .001]; ARD, 28.2% [95% CI, 24.6% to 31.8%]; P value for interaction, .02). Conclusions and Relevance: Among patients with cerebellar ICH, surgical hematoma evacuation, compared with conservative treatment, was not associated with improved functional outcome. Given the null primary outcome, investigation is necessary to establish whether there are differing associations based on hematoma volume.

Indexed as

Conservative TreatmentAgedCerebellar DiseasesCerebellumCerebral HemorrhageFemaleHematomaHumansMaleObservational Studies as TopicTreatment Outcome

Identifiers

PMID31593272
PMCPMC6784768
OpenAlexW2980011146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.